Schizophrenia Trial, Recruiting (NCT06886945)

Schizophrenia Trial, Recruiting NCT06886945 Sponsor: IRCCS Centro San Giovanni di Dio Fatebenefratelli Condition: Schizophrenia

Printed from Voxsanity (voxsanity.com.au) — NCT06886945 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Schizophrenia

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

All participants must meet these criteria:

Having normal hearing
Having normal vision, or vision that is fully corrected with glasses or contact lenses

People joining as patients must also meet these criteria:

Having a formal diagnosis of schizophrenia spectrum disorder, based on the DSM-5 diagnostic guidelines
Having an IQ score above 70

Who may not be able to join:

All participants:

Having a past or current condition affecting the brain or central nervous system

People joining as patients:

Currently having a serious physical health illness
Having had issues with drug dependency or substance misuse in the last 6 months
Being on a medication plan that is not yet stable or settled
Having an additional major psychiatric diagnosis alongside the schizophrenia spectrum disorder

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 8 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06886945

Sponsor: IRCCS Centro San Giovanni di Dio Fatebenefratelli

Phase: Not Applicable

Status: Recruiting

Condition: Schizophrenia

More information: https://clinicaltrials.gov/study/NCT06886945

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

All participants must meet these criteria:

Having normal hearing
Having normal vision, or vision that is fully corrected with glasses or contact lenses

People joining as patients must also meet these criteria:

Having a formal diagnosis of schizophrenia spectrum disorder, based on the DSM-5 diagnostic guidelines
Having an IQ score above 70

Who may not be able to join:

All participants:

Having a past or current condition affecting the brain or central nervous system

People joining as patients:

Currently having a serious physical health illness
Having had issues with drug dependency or substance misuse in the last 6 months
Being on a medication plan that is not yet stable or settled
Having an additional major psychiatric diagnosis alongside the schizophrenia spectrum disorder

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 8 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

IRCCS Centro San Giovanni di Dio Fatebenefratelli

Registry

ClinicalTrials.gov

Start date

9 April 2024

Est. completion

1 October 2025

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Temporal Binding Window (TBW) length

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov